337 related articles for article (PubMed ID: 22421440)
21. K-ras-2 topographic genotyping of pancreatic adenocarcinoma.
Finkelstein SD; Przygodzki R; Pricolo VE; Sayegh R; Bakker A; Swalsky PA; Keller G
Arch Surg; 1994 Apr; 129(4):367-72; discussion 372-3. PubMed ID: 8154963
[TBL] [Abstract][Full Text] [Related]
22. Sleeping Beauty insertional mutagenesis screen identifies the pro-metastatic roles of CNPY2 and ACTN2 in hepatocellular carcinoma tumor progression.
Lo LH; Lam CY; To JC; Chiu CH; Keng VW
Biochem Biophys Res Commun; 2021 Feb; 541():70-77. PubMed ID: 33482578
[TBL] [Abstract][Full Text] [Related]
23. p120 Catenin Suppresses Basal Epithelial Cell Extrusion in Invasive Pancreatic Neoplasia.
Hendley AM; Wang YJ; Polireddy K; Alsina J; Ahmed I; Lafaro KJ; Zhang H; Roy N; Savidge SG; Cao Y; Hebrok M; Maitra A; Reynolds AB; Goggins M; Younes M; Iacobuzio-Donahue CA; Leach SD; Bailey JM
Cancer Res; 2016 Jun; 76(11):3351-63. PubMed ID: 27032419
[TBL] [Abstract][Full Text] [Related]
24. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
25. A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer.
Rad R; Rad L; Wang W; Strong A; Ponstingl H; Bronner IF; Mayho M; Steiger K; Weber J; Hieber M; Veltkamp C; Eser S; Geumann U; Öllinger R; Zukowska M; Barenboim M; Maresch R; Cadiñanos J; Friedrich M; Varela I; Constantino-Casas F; Sarver A; Ten Hoeve J; Prosser H; Seidler B; Bauer J; Heikenwälder M; Metzakopian E; Krug A; Ehmer U; Schneider G; Knösel T; Rümmele P; Aust D; Grützmann R; Pilarsky C; Ning Z; Wessels L; Schmid RM; Quail MA; Vassiliou G; Esposito I; Liu P; Saur D; Bradley A
Nat Genet; 2015 Jan; 47(1):47-56. PubMed ID: 25485836
[TBL] [Abstract][Full Text] [Related]
26. Sleeping Beauty mutagenesis in a mouse medulloblastoma model defines networks that discriminate between human molecular subgroups.
Genovesi LA; Ng CG; Davis MJ; Remke M; Taylor MD; Adams DJ; Rust AG; Ward JM; Ban KH; Jenkins NA; Copeland NG; Wainwright BJ
Proc Natl Acad Sci U S A; 2013 Nov; 110(46):E4325-34. PubMed ID: 24167280
[TBL] [Abstract][Full Text] [Related]
27. Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.
Chen L; Jenjaroenpun P; Pillai AM; Ivshina AV; Ow GS; Efthimios M; Zhiqun T; Tan TZ; Lee SC; Rogers K; Ward JM; Mori S; Adams DJ; Jenkins NA; Copeland NG; Ban KH; Kuznetsov VA; Thiery JP
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2215-E2224. PubMed ID: 28251929
[TBL] [Abstract][Full Text] [Related]
28. K-ras point mutation in the nerve plexuses around the superior mesenteric artery in resectable adenocarcinoma of the pancreatic head: distribution pattern and related factors.
Ohigashi H; Ishikawa O; Sasaki Y; Yamada T; Furukawa H; Imaoka S; Kasugai T; Ishiguro S; Ueda K; Miyoshi Y; Nakamura Y
Arch Surg; 2000 Dec; 135(12):1450-5. PubMed ID: 11115351
[TBL] [Abstract][Full Text] [Related]
29. Sleeping Beauty transposon insertional mutagenesis based mouse models for cancer gene discovery.
Moriarity BS; Largaespada DA
Curr Opin Genet Dev; 2015 Feb; 30():66-72. PubMed ID: 26051241
[TBL] [Abstract][Full Text] [Related]
30. Insertional engineering of chromosomes with Sleeping Beauty transposition: an overview.
Grabundzija I; Izsvák Z; Ivics Z
Methods Mol Biol; 2011; 738():69-85. PubMed ID: 21431720
[TBL] [Abstract][Full Text] [Related]
31. Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies.
Tschida BR; Largaespada DA; Keng VW
Semin Cell Dev Biol; 2014 Mar; 27():86-95. PubMed ID: 24468652
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.
Lu L; Zeng J
PLoS One; 2017; 12(7):e0181532. PubMed ID: 28742845
[TBL] [Abstract][Full Text] [Related]
33. Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression.
Court H; Amoyel M; Hackman M; Lee KE; Xu R; Miller G; Bar-Sagi D; Bach EA; Bergö MO; Philips MR
J Clin Invest; 2013 Nov; 123(11):4681-94. PubMed ID: 24216479
[TBL] [Abstract][Full Text] [Related]
34. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.
Ge W; Goga A; He Y; Silva PN; Hirt CK; Herrmanns K; Guccini I; Godbersen S; Schwank G; Stoffel M
Gastroenterology; 2022 Jan; 162(1):269-284. PubMed ID: 34547282
[TBL] [Abstract][Full Text] [Related]
35. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice.
Dupuy AJ; Rogers LM; Kim J; Nannapaneni K; Starr TK; Liu P; Largaespada DA; Scheetz TE; Jenkins NA; Copeland NG
Cancer Res; 2009 Oct; 69(20):8150-6. PubMed ID: 19808965
[TBL] [Abstract][Full Text] [Related]
36. SB Digestor: a tailored driver gene identification tool for dissecting heterogeneous Sleeping Beauty transposon-induced tumors.
Zhang A; Wang L; Lei JH; Miao Z; Valecha MV; Hu P; Miao K; Deng CX
Int J Biol Sci; 2023; 19(6):1764-1777. PubMed ID: 37063417
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation.
Ahmed MM; Sheldon D; Fruitwala MA; Venkatasubbarao K; Lee EY; Gupta S; Wood C; Mohiuddin M; Strodel WE
Int J Cancer; 2008 Jan; 122(1):63-70. PubMed ID: 17893871
[TBL] [Abstract][Full Text] [Related]
38. Sleeping Beauty Transposon Mutagenesis as a Tool for Gene Discovery in the NOD Mouse Model of Type 1 Diabetes.
Elso CM; Chu EP; Alsayb MA; Mackin L; Ivory ST; Ashton MP; Bröer S; Silveira PA; Brodnicki TC
G3 (Bethesda); 2015 Oct; 5(12):2903-11. PubMed ID: 26438296
[TBL] [Abstract][Full Text] [Related]
39. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
Tada M; Omata M; Ohto M
Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
Niedergethmann M; Rexin M; Hildenbrand R; Knob S; Sturm JW; Richter A; Post S
Am J Surg Pathol; 2002 Dec; 26(12):1578-87. PubMed ID: 12459624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
